Syncona’s Autolus and BioNTech forge alliance to propel CAR-T therapies

Pallavi Madhiraju- February 11, 2024 0

Syncona Ltd, a prominent investor in the life sciences sector, has announced a significant strategic collaboration through its portfolio company, Autolus Therapeutics plc, with BioNTech ... Read More

BioNTech to buy UK-based tech firm InstaDeep for AI-powered drug discovery

Raghuram Kadari- January 11, 2023 0

German biotechnology company BioNTech has agreed to acquire 100% of the remaining InstaDeep shares for an upfront consideration of around £362 million in cash and ... Read More

FDA grants EUA for Omicron-adapted Covid-19 vaccine for children below five

Raghuram Kadari- December 9, 2022 0

Pfizer and BioNTech have received the US Food and Drug Administration (FDA) emergency use authorization (EUA) for their Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine for children ... Read More

BioNTech to launch construction of mRNA-based vaccine facility in Africa

pallavi123- October 27, 2021 0

BioNTech revealed plans to launch the construction of a manufacturing plant for mRNA-based vaccines in the African Union mid-next year. The German biotech company said ... Read More

Pfizer withdraws emergency use application for COVID-19 vaccine in India

pharmanewsdaily- February 5, 2021 0

US pharmaceutical giant Pfizer has withdrawn its application for emergency use authorization of its BNT162b2 COVID-19 vaccine in India. This decision comes after a series ... Read More

Switzerland approves Pfizer-BioNTech Covid-19 vaccine for emergency use, marking global first

pharmanewsdaily- December 20, 2020 0

Switzerland has become the first country to grant full approval for the Pfizer-BioNTech BNT162b2 Covid-19 vaccine, making a significant move in the global race against ... Read More

Pfizer and BioNTech’s COVID-19 vaccine secures FDA emergency use authorization

pharmanewsdaily- December 11, 2020 0

In a groundbreaking move, Pfizer and BioNTech have received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for their COVID-19 vaccine, ... Read More

Pfizer and BioNTech secure Health Canada approval for BNT162b2 Covid-19 vaccine

pharmanewsdaily- December 9, 2020 0

Pfizer, a leading global pharmaceutical company, and BioNTech, a prominent German biotech firm, have officially secured Health Canada's approval for their BNT162b2 vaccine. This approval, ... Read More

UK grants emergency authorization for Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine

pharmanewsdaily- December 2, 2020 0

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted emergency use authorization (EUA) for the BNT162b2 Covid-19 vaccine candidate, developed by Pfizer and ... Read More

BNT162b2 Covid-19 vaccine candidate more than 90% effective in phase 3 trial, say Pfizer and BioNTech

pharmanewsdaily- November 10, 2020 0

Pfizer and BioNTech announced that the BNT162b2 mRNA-based vaccine candidate has been shown to be more than 90% effective in the prevention of Covid-19 in ... Read More